Aspen Aerogels (NYSE:ASPN - Get Free Report) had its price target lowered by investment analysts at Barclays from $25.00 to $13.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an "overweight" rating on the construction company's stock. Barclays's target price points to a potential upside of 61.79% from the stock's previous close.
A number of other analysts have also recently commented on ASPN. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 14th. Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. Roth Mkm lowered their price target on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research report on Friday, February 14th. StockNews.com raised Aspen Aerogels to a "sell" rating in a research report on Wednesday. Finally, Craig Hallum decreased their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $22.44.
View Our Latest Analysis on Aspen Aerogels
Aspen Aerogels Stock Down 1.4 %
Shares of Aspen Aerogels stock traded down $0.12 during trading on Wednesday, reaching $8.04. The company's stock had a trading volume of 2,201,033 shares, compared to its average volume of 2,133,322. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a market cap of $659.27 million, a price-to-earnings ratio of 50.22 and a beta of 2.14. Aspen Aerogels has a 1-year low of $7.96 and a 1-year high of $33.15. The company has a 50-day simple moving average of $11.75 and a two-hundred day simple moving average of $18.15.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, equities analysts forecast that Aspen Aerogels will post 0.22 earnings per share for the current year.
Institutional Investors Weigh In On Aspen Aerogels
A number of large investors have recently made changes to their positions in ASPN. Abbot Financial Management Inc. lifted its position in Aspen Aerogels by 3.9% during the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company's stock worth $359,000 after buying an additional 1,146 shares in the last quarter. Franklin Resources Inc. lifted its position in Aspen Aerogels by 5.3% in the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company's stock valued at $815,000 after buying an additional 1,483 shares during the last quarter. Invesco Ltd. increased its stake in Aspen Aerogels by 3.5% during the fourth quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock worth $604,000 after purchasing an additional 1,724 shares during the period. Greenwood Capital Associates LLC increased its stake in Aspen Aerogels by 5.0% during the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock worth $439,000 after purchasing an additional 1,749 shares during the period. Finally, MetLife Investment Management LLC increased its stake in Aspen Aerogels by 6.3% during the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock worth $425,000 after purchasing an additional 2,118 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.
About Aspen Aerogels
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.